Talphera (TLPH) Change in Accured Expenses (2010 - 2026)
Talphera (TLPH) posted quarterly Change in Accured Expenses of -$252000.0 for Q1 2026, up 19.49% year-over-year from -$210898.4 in Q1 2025, and down 146.15% quarter-over-quarter from $546000.0 in Q4 2025.
Talphera (TLPH) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Talphera's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$252000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 19.49% year-over-year to -$252000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 428.18% YoY), while the FY2025 annual figure was $1.3 million, up 205.11% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$252000.0, down from $546000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $891000.0 in Q3 2025, with the low at -$1.5 million in Q1 2022.
- The 5-year median for Change in Accured Expenses is -$157000.0 (2022), against an average of -$172705.9.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 538.57% in 2023, then surged 991.0% in 2025.
- Talphera's Change in Accured Expenses stood at -$157000.0 in 2022, then soared by 500.64% to $629000.0 in 2023, then sank by 161.84% to -$389000.0 in 2024, then surged by 240.36% to $546000.0 in 2025, then plunged by 146.15% to -$252000.0 in 2026.
- Business Quant data shows TLPH's Change in Accured Expenses at -$252000.0 in Q1 2026, $546000.0 in Q4 2025, and $891000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | 787,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 787,000.00 |
| Jun 30, 2026 | 787,000.00 |
| Mar 31, 2026 | -252,000.00 |
| Mar 31, 2026 | -252,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | -313,000.00 |
| Mar 31, 2025 | -313,000.00 |
| Dec 31, 2024 | -389,000.00 |
| Dec 31, 2024 | -389,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |